18th European Congress: Perspectives in Lung Cancer Madrid, Spain 3-4 March 2017

Description:
The 18th European Congress: Perspectives in Lung Cancer on 3-4 March 2017 provides valuable information on new treatment algorithms, targeted drugs, diagnostics, better use of chemotherapy, and key clinical trials data for management of patients with lung cancer.

Knowing the most-up-to-date techniques and data for developing strategies to personalize therapies for your patients is essential for best practices. A significant amount of practice changing data that affects the optimal way to treat, manage and care for your patients with lung cancer has been presented recently. Guided by world-renowned lung cancer experts, Perspectives in Lung Cancer will not only provide a comprehensive overview of the most significant advances in lung cancer treatment, but will aid attendees in confirming their current practices and optimizing their patient care.

Nearly 250 physicians, nurses, and other healthcare professionals attend Perspectives in Lung Cancer annually.

Prices:
Physician Discounted Rate: EUR 549
Physician Early Rate: EUR 649
Physician Regular Rate: EUR 749
Nurse, Fellow, Residents, Student, and Trainee Discounted Rate: EUR 249
Nurse, Fellow, Residents, Student, and Trainee Early Rate: EUR 299
Nurse, Fellow, Residents, Student, and Trainee Regular Rate: EUR 349
Pharmaceutical Industry: EUR 925

Speakers: Scagliotti, Baas, Aerts, Crinò, Dziadziuszko, Fennell, Girard, Gosney, Irion, Novello, Pérol, Quoix, Vansteenkiste